Question 1

Does Verition Fund Management own AMLX stock?

Accepted Answer

No. Verition Fund Management exited its AMLX (Amylyx Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 13,264 shares worth $184,370.

Question 2

How many shares of AMLX does Verition Fund Management own?

Accepted Answer

None since Q2 2026, when Verition Fund Management exited the position. Its Q1 2026 13F listed 13,264 shares worth $184,370.

Question 3

What is Verition Fund Management's AMLX position worth?

Accepted Answer

Verition Fund Management's AMLX position was worth $184,370 in its Q1 2026 13F, before the exit in Q2 2026.

Question 4

Is Verition Fund Management buying or selling AMLX?

Accepted Answer

In Q2 2026, Verition Fund Management exited its entire AMLX position.

Question 5

When did Verition Fund Management first buy AMLX?

Accepted Answer

Verition Fund Management already held AMLX in its Q1 2022 13F, the earliest on record, and listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$17.96	0
2026-Q1	Decreased	13,264	-55.0%	$184,370	0.0%	$14.11	0
2025-Q4	Decreased	29,487	-53.9%	$356,203	0.0%	$12.00	0
2025-Q3	New	63,896	—	$868,347	0.0%	$14.90	34
2025-Q2	Exited	0	-100.0%	$0	0.0%	$6.33	0
2025-Q1	New	24,013	—	$85,006	0.0%	$3.66	30